Publication | Closed Access

High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7)

High-dose Intensity OxaliplatinMedicinePharmacologyColorectal CancerMetastatic Colorectal CancerPharmacotherapyFolfox 7Cancer TreatmentOncologyRadiation Oncology